Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2018 Dec 24

PMID 30580374

Citations 7

Authors

Hua-Fei Liu

Ji-Xin Wang

Dong-Quan Zhang

Si-Heng Lan

Qi-Xin Chen

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Elderly patients with Ewing sarcoma have a very poor prognosis, and treatment remains a challenge. However, the outcomes and potential prognostic factors of elderly Ewing sarcoma patients are rarely documented. Therefore, we investigated the prognosis of this special cohort and determine independent prognostic factors. MATERIAL AND METHODS A cohort of Ewing sarcoma patients aged over 40 years from 1973 to 2015 was identified from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database. The Kaplan-Meier method and a Cox proportional hazard regression model were used for the prognostic analysis. RESULTS A total of 162 patients were included with a mean age of 53 years. The 5-year overall survival (OS) and cancer-specific survival (CSS) rates of the entire group were 43.7% and 47.9%, respectively. The sex, location, tumor size, and radiation treatment had no effect on survival outcomes on univariate analysis. Tumor stage, surgery, and chemotherapy were significant indicators of both OS and CSS on multivariable analysis. CONCLUSIONS Surgery in combination with chemotherapy had a significant survival benefit in elderly Ewing sarcoma patients and should be recommended.

Citing Articles

Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database.

Braaten M, Braaten J, Chaddha J, Hu R, Lanoue C, Silberstein P Eur J Med Res. 2024; 29(1):29.

PMID: 38183148 PMC: 10768101. DOI: 10.1186/s40001-023-01599-1.

Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?.

Asanuma K, Nakamura T, Okamoto T, Hagi T, Kita K, Nakamura K BMC Cancer. 2022; 22(1):1075.

PMID: 36258189 PMC: 9580209. DOI: 10.1186/s12885-022-10106-4.

Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income country.

Panda G, Chandrasekharan A, Das S, Bhargava P, Srinivas S, Laskar S Ecancermedicalscience. 2022; 16:1361.

PMID: 35685954 PMC: 9085161. DOI: 10.3332/ecancer.2022.1361.

Age as a Prognostic Factor in Patients with Ewing Sarcoma-The Polish Sarcoma Group Experience.

Jagodzinska-Mucha P, Raciborska A, Kosela-Paterczyk H, Kozak K, Bilska K, Switaj T J Clin Med. 2021; 10(16).

PMID: 34441922 PMC: 8397138. DOI: 10.3390/jcm10163627.

Challenges of Diagnosing Primary Ewing's Sarcoma in the Small Intestine of the Elderly: A Case Report.

Yang J, Wei H, Lin Y, Lin N, Wu S, Yu X Front Oncol. 2021; 11:565196.

PMID: 34307115 PMC: 8299103. DOI: 10.3389/fonc.2021.565196.

References

Cotterill S, Parker L, Malcolm A, Reid M, More L, Craft A . Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer. 2000; 83(3):397-403. PMC: 2374562. DOI: 10.1054/bjoc.2000.1313. View

Carsi B, Rock M . Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res. 2002; (397):53-61. DOI: 10.1097/00003086-200204000-00008. View

Grimer R, Cannon S, Taminiau A, Bielack S, Kempf-Bielack B, Windhager R . Osteosarcoma over the age of forty. Eur J Cancer. 2003; 39(2):157-63. DOI: 10.1016/s0959-8049(02)00478-1. View

Dunst J, Schuck A . Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer. 2004; 42(5):465-70. DOI: 10.1002/pbc.10446. View

Manoso M, Healey J, Boland P, Athanasian E, Maki R, Huvos A . De novo osteogenic sarcoma in patients older than forty: benefit of multimodality therapy. Clin Orthop Relat Res. 2005; 438:110-5. DOI: 10.1097/01.blo.0000179587.42350.4d. View

Nishida Y, Isu K, Ueda T, Nishimoto Y, Tsuchiya H, Wada T . Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group. J Surg Oncol. 2009; 100(1):48-54. DOI: 10.1002/jso.21287. View

Subbiah V, Anderson P, Lazar A, Burdett E, Raymond K, Ludwig J . Ewing's sarcoma: standard and experimental treatment options. Curr Treat Options Oncol. 2009; 10(1-2):126-40. DOI: 10.1007/s11864-009-0104-6. View

Maheshwari A, Cheng E . Ewing sarcoma family of tumors. J Am Acad Orthop Surg. 2010; 18(2):94-107. DOI: 10.5435/00124635-201002000-00004. View

Lee J, Hoang B, Ziogas A, Zell J . Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer. 2010; 116(8):1964-73. DOI: 10.1002/cncr.24937. View

10.

Gupta A, Pappo A, Saunders N, Hopyan S, Ferguson P, Wunder J . Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010; 116(13):3189-94. DOI: 10.1002/cncr.25144. View

11.

Biswas B, Rastogi S, Khan S, Mohanti B, Sharma D, Sharma M . Outcomes and prognostic factors for Ewing-family tumors of the extremities. J Bone Joint Surg Am. 2014; 96(10):841-9. DOI: 10.2106/JBJS.M.00411. View

12.

Duchman K, Gao Y, Miller B . Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database. Cancer Epidemiol. 2015; 39(2):189-95. DOI: 10.1016/j.canep.2014.12.012. View

13.

Gaspar N, Hawkins D, Dirksen U, Lewis I, Ferrari S, Le Deley M . Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. J Clin Oncol. 2015; 33(27):3036-46. DOI: 10.1200/JCO.2014.59.5256. View

14.

Ning M, Perkins S, Borinstein S, Holt G, Stavas M, Shinohara E . Role of radiation in the treatment of non-metastatic osseous Ewing sarcoma. J Med Imaging Radiat Oncol. 2015; 60(1):119-28. DOI: 10.1111/1754-9485.12389. View

15.

Uyeturk U, Helvaci K, Demirci A, Sonmez O, Turker I, Afsar C . Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience. Contemp Oncol (Pozn). 2016; 20(2):141-6. PMC: 4925728. DOI: 10.5114/wo.2016.58487. View

16.

Cesari M, Righi A, Cevolani L, Palmerini E, Vanel D, Donati D . Ewing sarcoma in patients over 40 years of age: a prospective analysis of 31 patients treated at a single institution. Tumori. 2016; 102(5):481-487. DOI: 10.5301/tj.5000534. View

17.

Arshi A, Sharim J, Park D, Park H, Yazdanshenas H, Bernthal N . Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine. Spine J. 2016; 17(5):645-655. PMC: 5561729. DOI: 10.1016/j.spinee.2016.11.002. View

18.

Miller B, Gao Y, Duchman K . Does surgery or radiation provide the best overall survival in Ewing's sarcoma? A review of the National Cancer Data Base. J Surg Oncol. 2017; 116(3):384-390. DOI: 10.1002/jso.24652. View

19.

Li Y, Yang X, Zhang W, Yi C, Wang F, Li P . Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma. Cancer Manag Res. 2017; 9:443-451. PMC: 5628701. DOI: 10.2147/CMAR.S146827. View

20.

Ferrari S, Bielack S, Smeland S, Longhi A, Egerer G, Hall K . EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma. Tumori. 2017; 104(1):30-36. DOI: 10.5301/tj.5000696. View